Possible new therapeutic approach for obesity-related diseases: Role of adiponectin receptor agonists

Journal of Diabetes Investigation

Volumn 6, Issue 3, 2015, Pages 264-266

  Lee, Chien Hsing ^a   Hung, Yi Jen ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ADIPONECTIN RECEPTOR AGONIST; HORMONE RECEPTOR STIMULATING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

BLOOD LEVEL; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; EXERCISE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR UPREGULATION; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

EID: 84928269096     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12263     Document Type: Note

References (5)

1. Padmalayam I, Suto M. Role of adiponectin in the metabolic syndrome: current perspectives on its modulation as a treatment strategy. Curr Pharm Des 2013; 19: 5755-5763.
2. Lim S, Quon MJ, Koh KK. Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis 2014; 233: 721-728.
3. Okada-Iwabu M, Yamauchi T, Iwabu M, et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature 2013; 503: 493-499.
4. Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab 2013; 17: 185-196.
5. Greenhill C. Obesity: Adiponectin receptor agonists-possible therapeutic approach? Nat Rev Endocrinol 2014; 10: 4.